Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-008849

Chief Financial Officer sold 1,388 shares at $12.66 ($17,568)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ruffo Frank Chief Financial Officer 2022-02-09 Sale −1,388 $12.66 $17,568 172,359 D: show line 1 in the form
Open-market sales · 1,388 sh · avg $12.66 · $17,568
Loading xslF345X03/doc4.xml…